Literature DB >> 32421364

Challenges identifying efficacious miRNA therapeutics for cancer.

Meirav Segal1, Frank J Slack1.   

Abstract

Entities:  

Keywords:  Microrna; delivery; miRNA; nanoparticle; oligonucleotide; oncogene; tumor suppressor

Mesh：

Substances：

Year:  2020        PMID： 32421364      PMCID： PMC7415578          DOI： 10.1080/17460441.2020.1765770

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  37 in total

Review 1.  Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies.

Authors:  R James Christie; N Nishiyama; K Kataoka
Journal:  Endocrinology       Date:  2009-12-23       Impact factor: 4.736

Review 2.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

Review 3.  Cationic nanoparticles for cancer therapy.

Authors:  Erem Bilensoy
Journal:  Expert Opin Drug Deliv       Date:  2010-07       Impact factor: 6.648

4.  Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications.

Authors:  Scott R Suter; Alexi Ball-Jones; Madeline M Mumbleau; Rachel Valenzuela; Jose Ibarra-Soza; Hassan Owens; Andrew J Fisher; Peter A Beal
Journal:  Org Biomol Chem       Date:  2017-12-06       Impact factor: 3.876

Review 5.  microRNAs as oncogenes and tumor suppressors.

Authors:  Baohong Zhang; Xiaoping Pan; George P Cobb; Todd A Anderson
Journal:  Dev Biol       Date:  2006-08-16       Impact factor: 3.582

6.  miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.

Authors:  Nora Bandi; Erik Vassella
Journal:  Mol Cancer       Date:  2011-05-16       Impact factor: 27.401

Review 7.  RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

Authors:  Zhongji Meng; Mengji Lu
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 8.  Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.

Authors:  Xin Lai; Martin Eberhardt; Ulf Schmitz; Julio Vera
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

9.  Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In Vivo.

Authors:  Meirav Segal; Annabelle Biscans; Maud-Emmanuelle Gilles; Eleni Anastasiadou; Roberto De Luca; Jihoon Lim; Anastasia Khvorova; Frank J Slack
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-18       Impact factor: 8.886

10.  Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.

Authors:  Nadiya M Teplyuk; Erik J Uhlmann; Galina Gabriely; Natalia Volfovsky; Yang Wang; Jian Teng; Priya Karmali; Eric Marcusson; Merlene Peter; Athul Mohan; Yevgenya Kraytsberg; Ron Cialic; E Antonio Chiocca; Jakub Godlewski; Bakhos Tannous; Anna M Krichevsky
Journal:  EMBO Mol Med       Date:  2016-03-01       Impact factor: 12.137
View more
  26 in total

Review 1.  MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.

Authors:  Mamta Panda; Elora Kalita; Satyendra Singh; Ketan Kumar; Abhishek Rao; Vijay Kumar Prajapati
Journal:  Life Sci       Date:  2022-07-01       Impact factor: 6.780

Review 2.  Decoding microRNA drivers in atherosclerosis.

Authors:  Tanwi Vartak; Soundharya Kumaresan; Eoin Brennan
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 3.  A perspective to weaponize microRNAs against lung cancer.

Authors:  Dhanashree Murugan; Loganathan Rangasamy
Journal:  Noncoding RNA Res       Date:  2022-09-29

4.  Expression of miR-155 and miR-146a in the saliva of patients with periodontitis and its clinical value.

Authors:  Peng Wu; Jie Feng; Wei Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis.

Authors:  Fatemeh Radmanesh; Hamid Sadeghi Abandansari; Mohammad Hossein Ghanian; Sara Pahlavan; Fahimeh Varzideh; Saeed Yakhkeshi; Mehdi Alikhani; Sharif Moradi; Thomas Braun; Hossein Baharvand
Journal:  Angiogenesis       Date:  2021-03-19       Impact factor: 10.658

Review 6.  Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.

Authors:  Amro M Soliman; Teoh Seong Lin; Pasuk Mahakkanukrauh; Srijit Das
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 7.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

Review 8.  Regulation of autophagy by microRNAs in human breast cancer.

Authors:  Zhi Xiong Chong; Swee Keong Yeap; Wan Yong Ho
Journal:  J Biomed Sci       Date:  2021-03-25       Impact factor: 8.410

Review 9.  microRNAs as Novel Therapeutics in Cancer.

Authors:  Giulia Romano; Mario Acunzo; Patrick Nana-Sinkam
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 10.  Angiogenesis-related non-coding RNAs and gastrointestinal cancer.

Authors:  Zahra Sadat Razavi; Kasra Asgarpour; Maryam Mahjoubin-Tehran; Susan Rasouli; Haroon Khan; Mohammad Karim Shahrzad; Michael R Hamblin; Hamed Mirzaei
Journal:  Mol Ther Oncolytics       Date:  2021-05-15       Impact factor: 7.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.